World Investment Advisors bought a new stake in Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor bought 41,326 shares of the company’s stock, valued at approximately $1,169,000.
A number of other hedge funds also recently modified their holdings of REVS. Essex Financial Services Inc. lifted its holdings in shares of Columbia Research Enhanced Value ETF by 46.1% in the third quarter. Essex Financial Services Inc. now owns 11,811 shares of the company’s stock valued at $330,000 after purchasing an additional 3,725 shares in the last quarter. Private Advisor Group LLC purchased a new stake in shares of Columbia Research Enhanced Value ETF in the third quarter valued at $448,000. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Columbia Research Enhanced Value ETF by 11.2% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 100,569 shares of the company’s stock valued at $2,817,000 after purchasing an additional 10,095 shares in the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Columbia Research Enhanced Value ETF by 13.4% in the second quarter. NewEdge Advisors LLC now owns 122,687 shares of the company’s stock valued at $3,224,000 after purchasing an additional 14,498 shares in the last quarter. Finally, U.S. Capital Wealth Advisors LLC purchased a new stake in shares of Columbia Research Enhanced Value ETF in the fourth quarter valued at $3,446,000.
Columbia Research Enhanced Value ETF Price Performance
REVS opened at $30.76 on Monday. The stock has a fifty day moving average of $29.49 and a 200-day moving average of $29.07. The firm has a market capitalization of $282.99 million, a P/E ratio of 16.41 and a beta of 0.80. Columbia Research Enhanced Value ETF has a 12-month low of $24.92 and a 12-month high of $31.18.
About Columbia Research Enhanced Value ETF
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
Recommended Stories
- Five stocks we like better than Columbia Research Enhanced Value ETF
- As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
Want to see what other hedge funds are holding REVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
